Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadja M Meindl-Beinker

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Nature|December 14, 2007
Molecular code for transmembrane-helix recognition by the Sec61 transloconTara Hessa, Nadja M Meindl-Beinker, Andreas Bernsel, et al.
BMC Cancer|March 16, 2019
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)Nadja M Meindl-Beinker, Johannes Betge, Tobias Gutting, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Insertion of short transmembrane helices by the Sec61 transloconSimon Jaud, Mónica Fernández-Vidal, Ingmarie Nilsson, et al.
Journal of Hepatology|February 5, 2010
TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase ILoredana Ciuclan, Sabrina Ehnert, Iryna Ilkavets, et al.
European Journal of Gastroenterology & Hepatology|December 9, 2025
Medium distances to specialized care models at tertiary hospitals and socioeconomic neighborhood-related factors do not influence the quality of care for patients with liver cirrhosisSebastian H Michl, Nadja M Meindl-Beinker, Arash Dooghaie Moghadam, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2022
Characteristics and outcome of patients with small bowel adenocarcinoma (SBA)Andreas Teufel, Nadja M Meindl-Beinker, Pauline Hösel, et al.
Carcinogenesis|June 3, 2026
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent mannerDarko Castven, Sharon Pereira, Luis Z Rodriguez, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Protein Science : a Publication of the Protein Society|July 1, 2005
A scalable, GFP-based pipeline for membrane protein overexpression screening and purificationDavid Drew, Dirk-Jan Slotboom, Giulia Friso, et al.
Oncotarget|January 23, 2016
TGF-β1 and TGF-β2 abundance in liver diseases of mice and menAnne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Nature|December 14, 2007
Molecular code for transmembrane-helix recognition by the Sec61 transloconTara Hessa, Nadja M Meindl-Beinker, Andreas Bernsel, et al.
BMC Cancer|March 16, 2019
A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)Nadja M Meindl-Beinker, Johannes Betge, Tobias Gutting, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2009
Insertion of short transmembrane helices by the Sec61 transloconSimon Jaud, Mónica Fernández-Vidal, Ingmarie Nilsson, et al.
Journal of Hepatology|February 5, 2010
TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase ILoredana Ciuclan, Sabrina Ehnert, Iryna Ilkavets, et al.
European Journal of Gastroenterology & Hepatology|December 9, 2025
Medium distances to specialized care models at tertiary hospitals and socioeconomic neighborhood-related factors do not influence the quality of care for patients with liver cirrhosisSebastian H Michl, Nadja M Meindl-Beinker, Arash Dooghaie Moghadam, et al.
Journal of Cancer Research and Clinical Oncology|September 27, 2022
Characteristics and outcome of patients with small bowel adenocarcinoma (SBA)Andreas Teufel, Nadja M Meindl-Beinker, Pauline Hösel, et al.
Carcinogenesis|June 3, 2026
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent mannerDarko Castven, Sharon Pereira, Luis Z Rodriguez, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.
Protein Science : a Publication of the Protein Society|July 1, 2005
A scalable, GFP-based pipeline for membrane protein overexpression screening and purificationDavid Drew, Dirk-Jan Slotboom, Giulia Friso, et al.
Oncotarget|January 23, 2016
TGF-β1 and TGF-β2 abundance in liver diseases of mice and menAnne Dropmann, Tatjana Dediulia, Katja Breitkopf-Heinlein, et al.
Pageof 3